Skip to main content

Table 5 Comparison of unique variance in SCD severity explained by ASCQ-Me and PROMIS measures

From: Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠

Modela

 

Type III test statistics

F

Pb

ASCQ-Me & PROMIS measures on pain

I

ASCQ-Me Pain Impactd

10.78

<0.0011

PROMIS Pain Impact

3.15

0.0766

II

ASCQ-Me Pain Impactd

13.15

0.0003

PROMIS Pain Behavior

5.72

0.0172

III

PROMIS Pain Impactd

33.96

<0.0001

ASCQ-Me Pain Episode Frequency

1.16

0.2820

IV

PROMIS Pain Impactd

40.93

<0.0001

ASCQ-Me Pain Episode Severity

5.27

0.0221

V

PROMIS Pain Behaviord

33.07

<0.0001

ASCQ-Me Pain Episode Frequency

0.92

0.3381

VI

PROMIS Pain Behaviord

39.63

<0.0001

ASCQ-Me Pain Episode Severity

5.75

0.0169

ASCQ-Me & PROMIS measures of similar health domains

I

ASCQ-Me Stiffness Impactd

27.40

<0.0001

PROMIS Physical Functioningd

6.92

0.0088

II

ASCQ-Me Social Impactd

8.17

0.0045

PROMIS Satisfaction with Social Rolesd

5.63

0.0181

III

ASCQ-Me Social Impactd

17.07

<0.0001

PROMIS Satisfaction with Social Discretionary Activities

0.84

0.3594

IV

ASCQ-Me Emotional Impactd

6.94

0.0087

PROMIS Depression

1.50

0.2214

V

ASCQ-Me Emotional Impactd

13.10

0.0003

PROMIS Anxiety

0.04

0.8386

VI

ASCQ-Me Sleep Impactd

7.84

0.0053

PROMIS Sleep Disturbance

0.25

0.6194

VII

ASCQ-Me Sleep Impactd

14.24

0.0002

PROMIS Sleep Impairment

1.22

0.2694

  1. aAll regression models controlled for gender, age, and SCD genotype
  2. bThe criterion for significance was set at α = 0.05/3 = 0.0166 to control for the family-wise error rate given that the same measure is involved in three or fewer tests (e.g. PROMIS Pain Impact and Pain Behavior are involved in three tests)
  3. cThe criterion for significance was set at α = 0.05/2 = 0.025 to control for the family-wise error rate given that the same measure is involved in two or fewer tests (e.g. ASCQ-Me Social, Emotional and Sleep impact are involved in two tests)
  4. dStatistically significant unique variance associated with SCD severity after correction for multiple comparisons